-+ 0.00%
-+ 0.00%
-+ 0.00%

HUTCHMED Reports Phase III SACHI Trial Success for Savolitinib and Osimertinib in Advanced NSCLC

Reuters·01/14/2026 04:00:15

Please log in to view news